EARLY CARCINOMA ANTIGENS/ CANCER MARKERS IN ONCOLOGY/

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。本研究的目的是在组织、血液和体液中寻找新的癌症标志物（前列腺癌、结肠癌、乳腺癌、卵巢癌、肺癌、头颈癌、脑癌、胰腺癌、膀胱癌、肾癌、睾丸癌和其他癌症）。新的标记物可以使我们开发实验室测试，可以更早地诊断癌症和/或识别有不良结局风险的患者，并且可能受益于比常规护理通常推荐的更积极的治疗。参与本研究的癌症患者和正常健康个体。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to look for new cancer markers (prostate, colon, breast, ovarian, lung, head-neck, brain, pancreas, bladder, kidneys, testis, and other carcinoma cancers) in the tissue, blood, and body fluids. New markers may allow us to develop laboratory tests which can diagnose cancers earlier and/or identify patients who are at risk for a poor outcome and may benefit from more aggressive therapy than is normally recommended for routine care. Both cancer patients and normal, healthy individuals who will participate in this study.